Founded in 1995, Snibe is a global leading in-vitro diagnostic solution provider who has focused on the chemiluminescence immunoassay (CLIA) field for more than 29 years and also become the first CLIA manufacturer in China to get FDA-cleared. At present, we have provided customized diagnostic solutions to laboratories in more than 156 countries and regions. Over 30,000 units of Snibe's products have reached worldwide, including global chain labs and hospitals like Synlab, Eurofins, Cerba, Synevo, etc.

Snibe established 4 core R&D centers, including reagent, instrument,